Tsai, Nai-Wen
Chien, Li-Nien
Hung, Connie
Kuo, Amanda
Chiu, Yu-Ting
Lin, Hung-Wei
Jian, Li-Shan
Chou, Kai-Pei
Yeh, Jiann-Horng
Funding for this research was provided by:
UCB Pharma, Taipei, Taiwan
Article History
Received: 1 February 2024
Accepted: 5 April 2024
First Online: 27 April 2024
Declarations
:
: Connie Hung and Amanda Kuo are employees of UCB Pharma. Hung-Wei Lin, and Kai-Pei Chou are employees of IQVIA Solutions Taiwan Ltd. Li-Shan Jian is a former employee of IQVIA Solutions Taiwan Ltd., and the work was done while affiliated with IQVIA Solutions Taiwan Ltd.
: The study protocol was reviewed and approved by the Institutional Review Board (IRB) of Taipei Medical University (Approval number N202203018). Informed consent was waived because of the study’s descriptive and non-interventional nature, and the analysis was de-identified. This study was conducted in accordance with the Helsinki Declaration of 1964 and its later amendments.